Vanguard Group
INBS icon

Vanguard Group’s Intelligent Bio Solutions INBS Stock Holding History

Vanguard Group’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,769
Closed -$99.6K – 4366
2025
Q3 		$99.6K Buy
9,769
+8,220
+531% +$132K ﹤0.01% 4228
2025
Q2 		$26.6K Hold
1,549
– – ﹤0.01% 4233
2025
Q1 		$22.3K Hold
1,549
– – ﹤0.01% 4238
2024
Q4 		$21.7K Hold
1,549
– – ﹤0.01% 4258
2024
Q3 		$26.8K Hold
1,549
– – ﹤0.01% 4286
2024
Q2 		$29.7K Hold
1,549
– – ﹤0.01% 4334
2024
Q1 		$65.3K Buy
+1,549
New +$64.1K ﹤0.01% 4285
2023
Q1 		– Sell
-7
Closed -$3.38K – 4563
2022
Q4 		$3.38K Hold
7
– – ﹤0.01% 4525
2022
Q3 		$7K Hold
7
– – ﹤0.01% 4601
2022
Q2 		$11K Buy
+7
New +$11.8K ﹤0.01% 4618
2022
Q1 		– Sell
-16
Closed -$56K – 4634
2021
Q4 		$56K Buy
16
+6
+60% +$27.6K ﹤0.01% 4624
2021
Q3 		$61K Buy
10
+2
+25% +$15.3K ﹤0.01% 4539
2021
Q2 		$74K Buy
+8
New +$76.5K ﹤0.01% 4413

Other funds holding INBS

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CW
Curio Wealth Annapolis, Maryland $293M AUM 14.23% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
SWM
SHP Wealth Management Plymouth, Massachusetts $1.33B AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group's INBS Position: Q4 2025 in Review

Vanguard Group sold out of Intelligent Bio Solutions (INBS) in Q4 2025, closing a stake of 9,769 shares — an estimated $99.6K sold.

Vanguard Group first reported a position in INBS in Q2 2021 and held it in 13 quarters. The position peaked at $99.6K in Q3 2025. 7 funds tracked by Wall St. Rank hold INBS as of Q4 2025.

  • Vanguard Group reported no remaining Intelligent Bio Solutions position as of Q4 2025 after selling out during the quarter.
  • Vanguard Group sold 9,769 Intelligent Bio Solutions shares in Q4 2025, an estimated $99.6K.
  • Vanguard Group first reported a position in Intelligent Bio Solutions in Q2 2021 and held it in 13 quarters.
  • Vanguard Group's Intelligent Bio Solutions position peaked at $99.6K in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.